Floatz logo

GELDANAMYCIN, 17-DEMETHOXY-17-(2-PROPENYLAMINO)-

Stage III Adult Diffuse Mixed Cell Lymphoma

National Cancer Institute (NCI)Small moleculePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Stage III Adult Diffuse Mixed Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Fludarabine
Case Comprehensive Cancer Center
Phase 2BBB
Cyclophosphamide
University of Chicago
Phase 2BBB
Monomethyl Fumarate
University of Nebraska
Phase 2BB
CYCLOSPORIN A
National Cancer Institute (NCI)
Phase 2BB
TACROLIMUS
National Cancer Institute (NCI)
Phase 2BB

View all 49 →

Same molecule, other indications

GELDANAMYCIN, 17-DEMETHOXY-17-(2-PROPENYLAMINO)- is also rated in:

prostate cancerDormant
B
Indicative ·
59 / 100
View asset →
Hodgkins lymphomaDormant
B
Indicative ·
59 / 100
View asset →
mantle cell lymphomaDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →